Combined treatment with low-dose cyclosporine and calcipotriol/betamethasone dipropionate ointment for moderate-to-severe plaque psoriasis: a randomized controlled open-label study

By Vena Gino A.   Galluccio Antonia   Pezza Michele   Vestita Michelangelo   Cassano Nicoletta  

Journal of Dermatological Treatment, Vol. 23, Iss. 4, 2012-08 ,pp. : 255-260

Informa Healthcare

Access to resources Recommend Favorite

Open label trial of alefacept in palmoplantar pustular psoriasis

By Carr David   Tusa Mark   Carroll Christie   Pearce Daniel   Camacho Fabian   Kaur Mandeep   Cook Christina   Willard Joy   McCarty Ann   Fleischer Alan   Liu Clive   Goffe Bernard   Feldman Steven  

Journal of Dermatological Treatment, Vol. 19, Iss. 2, 2008-01 ,pp. : 97-100

Informa Healthcare

Access to resources Recommend Favorite

Ustekinumab in nail psoriasis: an open-label, uncontrolled, nonrandomized study

By Patsatsi Aikaterini   Kyriakou Aikaterini   Sotiriadis Dimitrios  

Journal of Dermatological Treatment, Vol. 24, Iss. 2, 2013-04 ,pp. : 96-100

Informa Healthcare

Access to resources Recommend Favorite

An update on drug–drug interactions with biologics for the treatment of moderate-to-severe psoriasis

By Gupta Rishu   Levin Ethan   Wu Jashin J.   Koo John   Liao Wilson  

Journal of Dermatological Treatment, Vol. 25, Iss. 1, 2014-02 ,pp. : 87-89

Informa Healthcare

Access to resources Recommend Favorite

Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis

By Martin Silas   Feldman Steven R.   Augustin Matthias   Szapary Philippe   Schenkel Brad  

Journal of Dermatological Treatment, Vol. 22, Iss. 3, 2011-06 ,pp. : 138-143

Informa Healthcare

Access to resources Recommend Favorite